SCHEMBL14215420

SCHEMBL14215420

CCCCC(C(=O)O)c1csc(C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.46
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PLA2G4A P47712 1/20 0.38
PDE1A P54750 2/20 0.37
PDE1B Q01064 2/20 0.37
PDE1C Q14123 2/20 0.37
ECE1 P42892 1/20 0.36
CA2 P00918 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 1/20 0.35
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35
KDM4A O75164 1/20 0.35
KDM4B O94953 1/20 0.35
KDM5C P41229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11922835 0.91 TDP1 (0.38) PDE5ARAB9ASMN1; SMN2ECE1KDM4A
SCHEMBL31555041 0.84 PDE5A (0.47) PDE5APLA2G4APDE1APDE1BPDE1C
SCHEMBL22383497 0.82 PKM (0.43) PDE5ARAB9AALDH1A1LMNAHPGD
SCHEMBL25413695 0.77 ECE1 (0.37) PDE5ARAB9AALDH1A1SMN1; SMN2ECE1
SCHEMBL8697796 0.76 LMNA (0.35) RAB9AALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL22692419 0.74 ATP4A (0.33) RAB9AALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL21236452 0.74 ATP4A (0.33) RAB9AALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL7186160 0.74 PDE5A (0.40) PDE5ALMNACA2MAPK1SLC1A3
SCHEMBL31555036 0.74 PDE5A (0.40) PDE5A
SCHEMBL2203044 0.74 ADRB3 (0.43) PDE5ARAB9AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative SHIONOGI & CO. LTD. (JP) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative CNR1, CNR2, HRH4 PDE5A 3772/4885RAB9A 2496/4885ALDH1A1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.